Saflufenacil

Saflufenacil is a broad-spectrum herbicide developed by BASF and belongs to the pyrimidinedione chemical group. It is classified as a Group 14 herbicide by the Weed Science Society of America (WSSA) and works by inhibiting the enzyme protoporphyrinogen oxidase (PPO), disrupting cell membrane function and causing susceptible weeds to die. It is primarily used for the control of broadleaf weeds in crops such as corn, soybean, cereals, cotton and other registered agricultural applications. It is marketed under product brands including Kixor®, Sharpen® and Heat®, depending on the market and formulation.

Saflufenacil is used for both pre-emergence and post-emergence weed management, particularly for burndown of emerged broadleaf weeds before crop planting and early-season weed control. It is also used in fallow management and in combination with other herbicides, including glyphosate, as part of integrated weed control programmes. Its activity against difficult-to-control broadleaf weeds makes it relevant to discussions on herbicide resistance management, weed control strategies and crop protection. However, repeated use of PPO inhibitors requires appropriate resistance-management practices, including rotation and combination with herbicides having different modes of action.

This section covers the latest Saflufenacil news, including herbicide registrations, product developments, regulatory reviews, scientific research and changes in weed management practices. Coverage also examines Group 14 herbicides, PPO inhibitor technology, broadleaf weed control, herbicide resistance, pesticide residues and environmental assessments. Updates follow developments by companies such as BASF and regulatory authorities, including the US EPA, Health Canada and Australia’s APVMA, as well as the evolving role of saflufenacil in global crop protection.